NAV lending, explained

NAV lending, or NAV financing, is when a private equity fund borrows money using its portfolio of investments as collateral. Instead of the fund's individual portfolio companies taking on debt (the traditional way PE uses leverage), the fund itself takes on debt at the fund level, secured by the value of all the companies it owns. NAV stands for Net Asset Value, which is the lender's estimate of the fund's portfolio value minus its obligations. NAV lending emerged as a niche product for fund-level liquidity around 2015, then exploded in 2022-2024 as traditional exit paths slowed. It is now one of the fastest-growing corners of private markets finance, with over $150 billion of deals outstanding and growing. It is also one of the most controversial, because it introduces a new layer of leverage at the fund level that most LPs did not sign up for when they committed capital.

That is the textbook answer. Here is what actually happens.

How NAV lending actually works

A PE fund has raised $5 billion from LPs. Over six years, it has invested that capital into 15 portfolio companies. The LPs' capital is locked in; individual LPs cannot withdraw from the fund before it naturally exits.

By year six, the fund values its portfolio at $8 billion (reflecting the portfolio companies' growth and any valuation increases). But none of that value is liquid. The fund has no cash to distribute to LPs without selling a portfolio company, which in a soft exit market might mean accepting a discount.

The fund approaches a NAV lender. The lender agrees to provide a $1 billion loan, secured by the fund's $8 billion portfolio. The loan has a 4-year term, interest paid quarterly (often at floating rates, LIBOR/SOFR +5-9%), and various covenants requiring the fund to maintain portfolio value above certain thresholds.

The fund can now use that $1 billion for one of several purposes.

Distributing to LPs. The fund takes the $1 billion and sends it to LPs as an interim distribution. LPs get cash back, the fund's reported IRR benefits from earlier cash flow, and the portfolio stays intact. The debt has to be repaid later, out of actual portfolio exits.

Following on into existing investments. The fund uses the cash to support portfolio companies that need more capital, either to fund tuck-in acquisitions or to address balance sheet issues.

Defensive capital. The fund holds the cash as a reserve in case portfolio companies get into distress and need rescue capital.

New investments at the fund level. In some structures, the fund can deploy the NAV loan into new investments, extending the fund's effective investment period.

Why it exploded after 2022

NAV lending was a small, specialised corner of the market until 2022. Then the M&A market seized up, IPOs dried up, and PE firms suddenly had portfolios full of mature assets they could not easily exit.

LPs started getting nervous. They had committed capital expecting distributions to start arriving by year 5-7 of each fund. Instead, funds were sitting on unrealised value and pushing for longer hold periods, more extensions, and continuation funds.

NAV lending became the pressure-relief valve. A fund could borrow against its own portfolio, distribute cash to LPs, and keep the portfolio intact, kicking the actual exit decision down the road.

The specialist lenders (17 Capital, Whitehorse Liquidity Partners, Hark, Pemberton, Ares, Blackstone GSO, KKR Capital Markets, etc.) saw opportunity and scaled up. LPs were initially cautious, then started demanding it as a feature rather than a bug of the funds they were committing to.

The mechanics, in more detail

NAV loans are structured with several important features.

Loan-to-value ratio. The lender typically lends 10-25% of the fund's NAV. A $5 billion portfolio might support $500m-$1.25bn of NAV lending. Higher LTVs are available but expensive, and they increase the risk of covenant breach if portfolio values drop.

Covenants. The lender requires the fund to maintain its NAV above a threshold (say, 3x the loan balance). If portfolio values drop below that threshold, the lender can force the fund to reduce the loan (by finding capital elsewhere or selling assets into a soft market, which is painful).

Interest rate. Floating rate, typically SOFR/LIBOR plus 500-900 basis points. At today's base rates, that is 9-14% all-in. Expensive debt.

Repayment profile. Most NAV loans are interest-only for the first few years, with balloon repayment at maturity. The fund's natural portfolio exits are supposed to generate the cash to repay. If exits do not materialise, the loan has to be refinanced or extended, often at less favorable terms.

Security. The lender has a first-priority lien on the fund's partnership interests, meaning the proceeds from any portfolio company exit flow to the lender before reaching LPs.

What LPs think about it

LPs are split.

Some LPs love it. Earlier liquidity, interim distributions that show up on quarterly reports, better reported IRRs. Cash in hand is better than paper gains, especially for LPs that need to recycle capital into new commitments.

Some LPs hate it. They did not sign up for additional fund-level leverage. The NAV loan creates a new priority creditor that gets paid before LPs. If portfolio performance disappoints, the LPs' residual value is subordinated to the loan. This is structurally worse than the fund they originally committed to.

Large, sophisticated LPs (CalPERS, Ontario Teachers, GIC, Mubadala, etc.) now explicitly ask about NAV lending plans during fund due diligence and often negotiate side letters restricting the GP's ability to use NAV loans without consent.

Smaller LPs often have less leverage to negotiate protections and accept NAV lending as a feature of the modern PE market.

The 2025/2026 controversy

NAV lending is currently controversial for three reasons.

Structural opacity. Most PE funds do not disclose their NAV loan terms in detail. LPs often do not know the covenants, the interest rate, or the counterparties. This is improving under regulatory pressure but still highly variable.

Valuation manipulation risk. The loan is sized off the fund's NAV, which is the GP's own valuation of its portfolio. GPs have incentive to maintain or increase portfolio valuations to avoid covenant breaches. Most sophisticated lenders run their own valuations, but the principal-agent problem is real.

Systemic risk. If a large number of PE funds have NAV loans at similar LTV levels, and if portfolio values drop materially in a downturn, a wave of covenant breaches could force forced sales into an illiquid market. Regulators have flagged this as a potential systemic risk. Whether it is actually systemic or just a localised PE problem is the subject of ongoing debate.

The moral hazard. NAV lending lets GPs avoid making the hard call on marginal portfolio companies. Rather than selling a struggling company at a weak price (accepting the L-shaped recovery), the GP can borrow against the healthy portfolio, extend the hold, and hope for better markets. This delays price discovery and can mask real performance issues.

When NAV lending works

NAV lending works well when:

• The fund's portfolio is genuinely strong and there is a clear path to natural exits within the loan's term
• The LTV is conservative (10-15%) so the margin of safety is meaningful
• The proceeds are used to fund real value-creation opportunities (follow-on acquisitions, follow-on investments at attractive prices) rather than just distributed to window-dress IRR
• LPs understand the structure and have consented

In those cases, NAV lending is a useful liquidity tool that bridges an illiquid asset class with LPs' cash needs.

When it does not

It works badly when:

• The LTV is aggressive (20%+) and the fund's portfolio performance is marginal
• The loan is used to make interim distributions that mask the lack of natural exits
• The interest burden exceeds the fund's realised distributions, so the fund is essentially borrowing to pay interest on previous borrowing
• The fund extends loans multiple times because exits keep not materialising

In those cases, NAV lending is a way to delay bad news rather than improve the underlying situation.

How to read a NAV loan disclosure

When you see a PE fund disclosure that mentions NAV financing or fund-level leverage, the useful questions are:

What is the loan-to-value ratio? Lower is safer. 10-15% is conservative; 20%+ is aggressive.

What is the interest rate? Higher rates mean more burden on the fund's cash flows. At SOFR +700bps in a 4.5% SOFR environment, that is ~11.5% all-in, a material drag.

What is the use of proceeds? Distributions to LPs is fine but arguably just window-dressing. Follow-on investments to support portfolio companies is more productive. Defensive reserves is reasonable but expensive.

What are the covenants? Portfolio-value-to-loan ratios of 3x or more are conservative. 2x is aggressive.

Who is the lender? Specialist NAV lenders (Hark, Whitehorse, 17 Capital) are more sophisticated and have specialised work-out capacity. Generalist lenders may be less flexible in distressed scenarios.

The closing take

NAV lending is a structural innovation in private markets finance that has exploded in 2022-2025 as exit markets have stayed slower than PE firms hoped. It is a legitimate tool for bridging liquidity needs in an illiquid asset class. It is also a mechanism that can mask real performance issues in underperforming funds by providing interim distributions that do not require actual exits.

The right question is not whether NAV lending is good or bad, but whether any particular fund's use of it is coherent with its actual portfolio performance. A fund using NAV lending to follow on into its best investments at attractive prices is doing something different from a fund using it to window-dress IRR on a portfolio that cannot find buyers.

Regulatory scrutiny will increase. LP protections will get stronger. Pricing will probably compress as more lenders enter the space. But the structural use case is real and here to stay.

For the broader picture of how PE firms use leverage, see the LBO model. For other tools PE firms use to pull cash out of portfolios, see dividend recapitalisations, sale-leasebacks, and the rest of the toolkit. For the big picture, start with what is private equity.